stock was weak again despite the likelihood CEO Elon Musk will step down as head of Twitter, and earnings estimates for 2023 are staying remarkably stable.

The price trend for CorMedix (CRMD) has been bearish lately and the stock has lost 14% over the past week. However, the ...